tiprankstipranks
National Healthcare Properties (HLTC)
OTHER OTC:HLTC
US Market
Want to see HLTC full AI Analyst Report?

National Healthcare Properties (HLTC) AI Stock Analysis

29 Followers

Top Page

HLTC

National Healthcare Properties

(OTC:HLTC)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
$8.50
▲(14.86% Upside)
Action:Reiterated
Date:05/18/26
The score is held back primarily by weak financial performance (ongoing losses, uneven cash flow, and mixed leverage clarity). This is partially offset by a favorable technical trend (price above key moving averages with positive MACD) and moderately positive corporate actions, while valuation remains a downside due to the loss-making profile and lack of dividend data.
Positive Factors
Preferred share tender offers
Repurchasing up to $100M of perpetual preferred stock is a structural capital‑structure action. Reducing preferred overhang lowers fixed dividend claims and preferred liquidation priority, improving long‑term cash flow available to common holders and simplifying funding needs.
Negative Factors
Persistent negative net income
Consistent net losses signal that after financing and non‑cash items the company fails to generate bottom‑line profits. Over the medium term this constrains retained earnings, limits distribution capacity for a REIT and raises reliance on external capital for growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Preferred share tender offers
Repurchasing up to $100M of perpetual preferred stock is a structural capital‑structure action. Reducing preferred overhang lowers fixed dividend claims and preferred liquidation priority, improving long‑term cash flow available to common holders and simplifying funding needs.
Read all positive factors

National Healthcare Properties (HLTC) vs. SPDR S&P 500 ETF (SPY)

National Healthcare Properties Business Overview & Revenue Model

Company Description
Healthcare Trust, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States....
How the Company Makes Money
null...

National Healthcare Properties Financial Statement Overview

Summary
Overall fundamentals are below average: profitability is persistently negative (income statement score 28) and cash flow is unstable despite a TTM rebound to positive operating cash flow and free cash flow (cash flow score 45). The balance sheet is mixed (score 52) with leverage signals that are difficult to interpret due to conflicting TTM debt reporting, reducing confidence in the financial snapshot.
Income Statement
28
Negative
Balance Sheet
52
Neutral
Cash Flow
45
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue-158.00K339.81M353.79M345.93M335.85M329.36M
Gross Profit-249.91M-33.14M132.65M128.13M122.40M123.54M
EBITDA162.04M82.02M-22.36M76.87M53.76M42.59M
Net Income-77.10M-71.07M-189.70M-72.30M-79.62M-85.18M
Balance Sheet
Total Assets1.70B1.71B1.95B2.15B2.18B2.21B
Cash, Cash Equivalents and Short-Term Investments52.81M57.62M21.65M46.41M53.65M59.74M
Total Debt0.00380.95M1.15B1.18B1.12B1.09B
Total Liabilities1.10B1.11B1.26B1.24B1.18B1.17B
Stockholders Equity592.16M600.06M684.56M894.15M992.64M1.03B
Cash Flow
Free Cash Flow8.87M-21.77M-101.75M-773.00K302.00K19.81M
Operating Cash Flow37.19M6.95M-79.85M21.62M28.30M38.88M
Investing Cash Flow-13.66M69.81M63.97M-62.82M-41.78M-47.92M
Financing Cash Flow-43.35M-42.40M-1.35M55.97M4.64M4.08M

National Healthcare Properties Technical Analysis

Technical Analysis Sentiment
Positive
Last Price7.40
Price Trends
50DMA
8.13
Positive
100DMA
7.86
Positive
200DMA
7.79
Positive
Market Momentum
MACD
0.10
Positive
RSI
56.80
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Positive. The current price of 7.4 is below the 20-day moving average (MA) of 8.47, below the 50-day MA of 8.13, and below the 200-day MA of 7.79, indicating a bullish trend. The MACD of 0.10 indicates Positive momentum. The RSI at 56.80 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLTC.

National Healthcare Properties Risk Analysis

National Healthcare Properties disclosed 86 risk factors in its most recent earnings report. National Healthcare Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Healthcare Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$176.96M2.38167.61%4.62%24.57%7.81%
62
Neutral
$501.15M42.081.41%12.08%5.24%
61
Neutral
$2.21B-9.23-18.75%0.80%0.39%-8.95%
56
Neutral
$580.42M27.8911.44%7.51%0.77%-4.74%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
52
Neutral
$241.50M-7.64-11.41%-2.13%44.66%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLTC
National Healthcare Properties
8.50
-0.65
-7.10%
DHC
Diversified Healthcare Trust
8.90
5.79
185.90%
CHCT
Community Healthcare
17.72
3.66
26.05%
UHT
Universal Health Realty Income
42.12
6.80
19.24%
STRW
Strawberry Fields REIT Inc
13.27
3.85
40.93%

National Healthcare Properties Corporate Events

Business Operations and StrategyStock Buyback
National Healthcare Properties Launches Preferred Share Tender Offers
Positive
May 18, 2026
On May 18, 2026, National Healthcare Properties launched concurrent tender offers to repurchase up to $100 million of its 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred shares at $22.50 per share in cash. The offers,...
Executive/Board ChangesShareholder Meetings
National Healthcare Properties Shareholders Approve Directors and Governance Items
Neutral
May 15, 2026
At its May 15, 2026 annual meeting, National Healthcare Properties, Inc. reported that shareholders representing about 50.42% of outstanding common stock were present in person or by proxy. Investors elected six directors, including Leslie D. Mich...
Business Operations and StrategyExecutive/Board Changes
National Healthcare Properties Adopts New Equity Incentive Awards
Positive
May 1, 2026
On April 30, 2026, National Healthcare Properties&#8217; board of directors approved listing equity awards tied to the completion of its offering, granting employees and named executive officers an aggregate 995,994 shares of common stock and LTIP...
Private Placements and FinancingRegulatory Filings and Compliance
National Healthcare Properties Prices Large Follow-On Equity Offering
Neutral
Apr 27, 2026
On April 23, 2026, National Healthcare Properties, Inc. closed an underwritten public offering of 38,500,000 shares of its Class A common stock, issued under an effective registration statement. The transaction was executed pursuant to an underwri...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
National Healthcare Properties Authorizes Class A Stock Offering
Positive
Apr 13, 2026
On April 10, 2026, National Healthcare Properties authorized up to 100,000,000 shares of Class A common stock in connection with a proposed public offering, with each Class A share set to automatically convert into one common share 180 days after ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 18, 2026